Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Lentiviral vectors.

Andrew M L Lever1, Padraig M Strappe, Jing Zhao

  • 1University of Cambridge, Department of Medicine, Addenbrooke's Hospital, Cambridge, UK. amll1@mole.bio.cam.ac.uk

Journal of Biomedical Science
|May 22, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Optimization of a lentivirus-mediated gene therapy targeting HIV-1 RNA to eliminate HIV-1-infected cells.

Molecular therapy. Nucleic acids·2024
Same author

Author Correction: Africa-specific human genetic variation near CHD1L associates with HIV-1 load.

Nature·2023
Same author

Africa-specific human genetic variation near CHD1L associates with HIV-1 load.

Nature·2023
Same author

Life changing response to successive surgical interventions on cranial venous outflow: A case report on chronic fatigue syndrome.

Frontiers in neurology·2023
Same author

HIV-1 Packaging Visualised by In-Gel SHAPE.

Viruses·2021
Same author

A novel role for gag as a cis-acting element regulating RNA structure, dimerization and packaging in HIV-1 lentiviral vectors.

Nucleic acids research·2021

Lentivirus vectors are advancing into clinical trials for gene therapy, offering unique integration into non-dividing cells. Despite some viral assembly unknowns, safe and effective vectors are now available for various tissues.

Area of Science:

  • Gene therapy
  • Viral vectors
  • Molecular biology

Background:

  • Lentivirus-based vectors are progressing towards clinical applications as gene delivery vehicles.
  • Significant knowledge from HIV research aids lentivirus vector development.
  • The ability to integrate genetic material into non-dividing cells is a key advantage.

Purpose of the Study:

  • To summarize the current state of lentivirus vector development for clinical applications.
  • To highlight the advantages and challenges in using lentivirus vectors for gene delivery.
  • To confirm the feasibility of producing safe and effective lentivirus vectors for specific tissues.

Main Methods:

  • Leveraging accumulated knowledge of HIV biology and viral assembly.
  • Developing protocols for high-titer lentivirus vector production.

Related Experiment Videos

  • Assessing vector efficacy in transducing growth-arrested cells.

    • Main Results:

    • Clinical studies utilizing lentivirus vectors have commenced.
    • Lentivirus vectors demonstrate unique capabilities for gene integration in non-dividing cells.
    • Safe, reproducible, high-titer vector preparations are achievable.

    Conclusions:

    • Lentivirus vectors are a promising tool for gene therapy, particularly for non-dividing cells.
    • Despite incomplete understanding of viral assembly, practical applications are feasible.
    • Effective transduction of neural tissue, muscle, and liver is possible with current lentivirus vector technology.